Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

“Debio 1453 represents an approach to resistance targeting that ... to offer a durable solution to treating gonorrhea, for which all but one antibiotic has been rendered ineffective,” said ...

Gonorrhea can also be transmitted from a ... About CARB-X CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to supporting ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

I’d just disclosed that I thought I had contracted gonorrhoea from kissing a stranger in a club. She said: ‘I haven’t heard ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Anger over the cuts to the CDC has shown up at town halls, protests, press conferences and rallies outside the center’s Atlanta campus. Navy blue signs saying “Save the CDC” and “Save Public Health” ...

A study warns that fluoride bans in public water systems may lead to 54 million extra decayed teeth and $19 billion in health ...